Russia-Iran: a Mutually Beneficial Exchange
Pharma products developed in Iran will be manufactured in Russia within the project for cooperation with Russian Petrovax Pharm.
Cooperation between our countries in the field of pharmaceutical production began long ago. In February an agreement between large pharmaceutical enterprise Sobhan Recombinant Protein and Russian specialized company Petrovax Pharm on manufacture in Iran of an influenza vaccine “Grippol Plus”, developed in Russia, was signed.
Now the three drugs with formulas developed in Iraq, will be manufactured in Russia. The Russian company will receive from Iran pharmacists a technology of full cycle production of hepatitis B vaccine.